Medical Journals to Require Registration of Drug Trials
The recent controversy about the safety of antidepressant medication
has brought another issue to the forefront. (Use the search function
in the sidebar and search for "antidepressant" to see other posts on
this subject.) For many years, there has been concern in the medical
profession abut the selective publication of drug trials. What this
means is that an experiment that shows that a drug works is more likely
to be published than an experiment that shows no effect. Thus, it is
possible for medical professionals to develop a false impression about
the effectiveness of a particular treatment.
That such selective publication could occur is surprising to many people. However, it order to understand it, it is important to understand the circumstances in which many of these experiments are done. In this post, I explain how this happened, what the medical profession is doing about it, and why it matters. I also mention some unintended consequences that are likely to result. Some are good; others not. Read the rest at The Rest of the Story.
That such selective publication could occur is surprising to many people. However, it order to understand it, it is important to understand the circumstances in which many of these experiments are done. In this post, I explain how this happened, what the medical profession is doing about it, and why it matters. I also mention some unintended consequences that are likely to result. Some are good; others not. Read the rest at The Rest of the Story.
<< Home